Interferon-γ links ultraviolet radiation to melanomagenesis in mice
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Cutaneous malignant melanoma is a highly aggressive and frequently chemoresistant cancer, the incidence of which continues to rise. Epidemiological studies show that the major aetiological melanoma risk factor is ultraviolet (UV) solar radiation, with the highest risk associated with intermittent burning doses, especially during childhood. We have experimentally validated these epidemiological findings using the hepatocyte growth factor/scatter factor transgenic mouse model, which develops lesions in stages highly reminiscent of human melanoma with respect to biological, genetic and aetiological criteria, but only when irradiated as neonatal pups with UVB, not UVA. However, the mechanisms underlying UVB-initiated, neonatal-specific melanomagenesis remain largely unknown. Here we introduce a mouse model permitting fluorescence-aided melanocyte imaging and isolation following in vivo UV irradiation. We use expression profiling to show that activated neonatal skin melanocytes isolated following a melanomagenic UVB dose bear a distinct, persistent interferon response signature, including genes associated with immunoevasion. UVB-induced melanocyte activation, characterized by aberrant growth and migration, was abolished by antibody-mediated systemic blockade of interferon-γ (IFN-γ), but not type-I interferons. IFN-γ was produced by macrophages recruited to neonatal skin by UVB-induced ligands to the chemokine receptor Ccr2. Admixed recruited skin macrophages enhanced transplanted melanoma growth by inhibiting apoptosis; notably, IFN-γ blockade abolished macrophage-enhanced melanoma growth and survival. IFN-γ-producing macrophages were also identified in 70% of human melanomas examined. Our data reveal an unanticipated role for IFN-γ in promoting melanocytic cell survival/immunoevasion, identifying a novel candidate therapeutic target for a subset of melanoma patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“UVB induces macrophage infiltration of melanomas by upregulating Ccr2103 and ATF2104.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“UVB regulates the recruitment of inflammatory cells into the skin, including macrophages103,104 and neutrophils105,106.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [103]
In the citing paper
“This positive feedback loop increases melanoma growth in vivo by reducing melanoma cell death103.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [103]
In the citing paper
“Upon recruitment, IFN-γ signaling from macrophages triggers further upregulation of Ccl8, a Ccr2 ligand, in melanocytes103.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
Bioinformatics and Computational Biology Solutions Using R and Bioconductor
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0 · Cited by 3,289
Defining the Epithelial Stem Cell Niche in Skin
Tumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W. E., Rendl, M., & Fuchs, E. (2004) · Science · doi:10.1126/science.1092436 · Cited by 2,031
Self-citationlumi: a pipeline for processing Illumina microarray
Du, P., Kibbe, W. A., & Lin, S. M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn224 · Cited by 2,019
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
DeNardo, D. G., Barreto, J. B., Andreu, P., Vasquez, L., Tawfik, D., Kolhatkar, N., & Coussens, L. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.018 · Cited by 1,353
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
Cited by
Items 201–293 of 293
Location, Location, Location: Spatio-Temporal Cues That Define the Cell of Origin in Melanoma
Soengas, M. S., & Patton, E. E. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.10.009 · Cited by 12
“Another method, neonatal UVB irradiation, has also been reported to mobilize melanocytes to drive epidermal melanoma with a marked inflammatory component (Zaidi et al., 2011).”
Gopalan, V., Wong, C. W., Leshem, R., Owen, L., Vallius, T., Shi, Y., Jiang, Y., Pérez‐Guijarro, E., Wu, E., Chin, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.14.512297 · Cited by 10
Self-citationIFN-γ affects pancreatic cancer properties by MACC1-AS1/MACC1 axis via AKT/mTOR signaling pathway
Xy, S., Zhang, X.-L., Shi, Q.-Y., Qiu, X., Wu, X., Zheng, B.-L., Jiang, H., & Qin, S. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02748-w · Cited by 13
Dinarello, A., Mills, T., Tengesdal, I. W., Powers, N. E., Azam, T., & Dinarello, C. A. (2023) · Cells · doi:10.3390/cells12020294 · Cited by 12
Lee, E., Choi, S. ‐., Bin, B.-H., Kim, N. ‐., Kim, K. H., Choi, D. H., Han, J., Choi, H., Lee, A. ‐., Lee, T. R., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14878 · Cited by 9
Motamedi, M., Xiao, M. Z. X., Iyer, A., & Gniadecki, R. (2021) · Cells · doi:10.3390/cells10061409 · Cited by 9
Ferguson, B., Kunisada, T., Aoki, H., Handoko, H. Y., & Walker, G. J. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c5pp00098j · Cited by 10
Parmiani, G., & Maccalli, C. (2012) · OncoImmunology · doi:10.4161/onci.21455 · Cited by 10
Interferon γ: An Overview of Its Functions in Health and Disease
Bae, H. R., Barlow, A. T., Young, H. A., & Valencia, J. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10006-2 · Cited by 15
Self-citationEpigenetic mechanisms in melanoma development and progression
Joo, H., Olea, X. D., Zhuang, A., Zheng, B., Kim, H., & Ronai, Z. A. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.04.007 · Cited by 9
Wang, X., Liu, P., Liu, H., Yang, W., Liu, Z., Zhuo, Z., & Gao, Y. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.65 · Cited by 9
Targeting the mercapturic acid pathway for the treatment of melanoma
Singhal, S. S., Srivastava, S., Mirzapoiazova, T., Horne, D. A., Awasthi, S., & Salgia, R. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.06.004 · Cited by 8
Mechanisms of Altered Immune Response in Skin Melanoma.
Fruntealată, R.-F., Marius, M., Boboc, I. K. Ş., Mitran, S. I., Ciurea, M. E., & Stoica, G. A. (2023) · PubMed Central · doi:10.12865/chsj.49.03.01 · Cited by 12
Interferon-γ Attenuates 5-Hydroxytryptamine-Induced Melanogenesis in Primary Melanocyte
Zhou, J., Ling, J., & Ping, F. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00914 · Cited by 10
ATF 2 alters melanocyte response and macrophage recruitment in UV‐irradiated neonatal mouse skin
Senft, D., Sorolla, A., Dewing, A., Claps, G., Lau, E., Walker, G. J., & Ronai, Z. A. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12382 · Cited by 7
“As the melanocyte response to neonatal UV-B expo- sure was previously linked to innate immune responses (Coleman et al., 2014; Zaidi et al., 2011), we further evaluated whether melanocyte-specific expression of the ATF2 deletion mutant influences immune cell recruitment.”
BackgroundDevelopment of a Macrophage-Related Risk Model for Metastatic Melanoma
Li, Z., Zhang, X., Jin, Q., Zhang, Q., Qi, Y., Fujimoto, M., & Jin, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813752 · Cited by 7
Hasterok, S., Jankovskaja, S., Dahlström, R. M., Prgomet, Z., Ohlsson, L., Björklund, S., & Gustafsson, A. (2024) · Biomolecules · doi:10.3390/biom14070815 · Cited by 11
“For instance, Zaidi et al. [61] discovered a significant mechanism in melanoma development, in which UVB exposure initiates melanocyte activation by inducing ligands that interact with the C-C chemokine receptor type 2 (CCR2).”
BackgroundThe HGF/SF Mouse Model of UV-Induced Melanoma as an In Vivo Sensor for Metastasis-Regulating Gene
Leonard, M. K., Pamidimukkala, N., Puts, G. S., Snyder, D. E., Slominski, A. T., & Kaetzel, D. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081647 · Cited by 8
“The utility of a Dct-driven, doxycycline-inducible transgene encoding a fusion of histone 2B and green fluorescence protein [79,80] illustrates the feasibility of such an approach.”
BackgroundAktary, Z., McMahon, M., & Larue, L. (2017) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_32-1 · Cited by 9
Clara, R. O., Aßmann, N., Moreno, A. C. R., Coimbra, J. B., Nurenberger, N., Dettmer‐Wilde, K., Oefner, P. J., & Čampa, A. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0173 · Cited by 7
McGonigle, T. A., Dwyer, A. R., Greenland, E. L., Scott, N. M., Carter, K. W., Keane, K. N., Newsholme, P., Goodridge, H. S., Pixley, F. J., & Hart, P. H. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700760 · Cited by 8
“The cytokines analyzed included IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 p40, IL-12 p70, IL-13, IL-17, Eotaxin (CCL11), G-CSF, GM-CSF, IFN-g, KC, MCP1, MIP-1a, MIP-1b, RANTES, and TNF-a.”
BackgroundInfluentialInhibition of anti-tumor immunity by melanoma cell-derived Activin-A depends on STING
Pinjušić, K., Ambrosini, G., Lourenço, J., Fournier, N., Iseli, C., Guex, N., Egorova, O., Nassiri, S., & Constam, D. B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1335207 · Cited by 8
Cui, Y.-Z., Xu, F., Zhou, Y., Wang, Z., Yang, X.-Y., Fu, N.-C., Chen, X., Zheng, Y., Chen, X., Ye, L., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.02.018 · Cited by 6
Rahiem, R. A. E., Ibrahim, S., Effat, H., El-Houseini, M. E., Osman, R., Abdelraouf, A., & Elzayat, E. M. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.5.1589 · Cited by 7
Goukassian, D. A., Sharov, A. A., Rhodes, J., Coleman, C., Eller, M. S., Sharova, T. Y., Bhawan, J., & Gilchrest, B. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.176 · Cited by 6
“Finally, pTT is known to have immunomodulatory effects (Cruz et al., 2000; Curiel-Lewandrowski et al., 2003) and may have modified interferon-mediated events recently shown to enhance melanomagenesis in mice following UV irradiation in the newborn period (Zaidi et al., 2011).”
BackgroundRodero, M. P., Handoko, H. Y., Villani, R. M., Walker, G. J., & Khosrotehrani, K. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.78 · Cited by 6
Braun, A. D., Mengoni, M., Bonifatius, S., Tüting, T., & Gaffal, E. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.12.020 · Cited by 6
Patel, A., Tong, S., Lozada, K. A., Awasthi, A., Silverman, R. B., Totonchy, J. E., & Yang, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060691 · Cited by 7
Aggarwal, A., Nasreen, A., Sharma, B., Sahoo, S., Aswin, K., Faruq, M., Pandey, R., Jolly, M. K., Singh, A., Gokhale, R. S., et al. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002776 · Cited by 6
Bonfiglio, R., Giacobbi, E., Palumbo, V., Casciardi, S., Sisto, R., Servadei, F., Scioli, M. P., Schiaroli, S., Cornella, E., Cervelli, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413388 · Cited by 5
Interaction Between the Immune System and Melanoma
Norma, E. (2013) · InTech eBooks · doi:10.5772/54939 · Cited by 5
Therapeutic Application of Melatonin in the Treatment of Melanoma: A Review
Fatemi, I., Dehdashtian, E., Pourhanifeh, M. H., Mehrzadi, S., & Hosseinzadeh, A. (2021) · Current Cancer Therapy Reviews · doi:10.2174/1573394717666210526140950 · Cited by 5
Ge, Y., Azuma, R., Gekonge, B., López-Coral, A., Xiao, M., Zhang, G., Xu, X., Montaner, L. J., Wei, Z., Herlyn, M., et al. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1237-8 · Cited by 5
“In melanoma, TAMs have been reported to play important roles in every stage of melanoma development, including melanoma initiation, anti-tumor immunity, angiogenesis and metastasis (Bernengo et al., 2000; Varney et al., 2005; Gazzaniga et al., 2007; Zaidi et al., 2011; Wang et al., 2012).”
The Macrophage: A New Factor in UVR-Induced Melanomagenesis
Wang, T., & Herlyn, M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.93 · Cited by 6
Crosstalk Between nNOS/NO and COX-2 Enhances Interferon-Gamma-Stimulated Melanoma Progression
Patel, A., Tong, S., Roosan, M. R., Syed, B., Awasthi, A., Silverman, R. B., & Yang, S. (2025) · Cancers · doi:10.3390/cancers17030477 · Cited by 5
“The results, along with accumulating evidence [10,12,17,26,27], provide insight into the pro-tumorigenic activity of IFN-γ and underscore the potential of targeting nNOS and COX-2 as promising pharmacotherapeutic approaches for melanoma by inhibiting IFN-γ -stimulated PD-L1 expression (Figure 9).”
Spatiotemporal Labeling of Melanocytes in Mice
Preston, S., Aras, S., & Zaidi, M. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051469 · Cited by 5
Self-citationEffect of anti-COVID-19 drugs on patients with cancer
Huang, W., Liu, W., Yu, T., Zhang, Z., Zhai, L., Huang, P., & Lü, Y. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116214 · Cited by 6
Immunogenomic precision medicine: a personalized approach based on immunogenomic cancer evolution
Momoi, Y., Kumagai, S., & Nishikawa, H. (2025) · International Immunology · doi:10.1093/intimm/dxaf020 · Cited by 5
Regulatory Role of Cannabinoids for Skin Barrier Functions and Cutaneous Inflammation
Tüting, T., & Gaffal, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00067-3 · Cited by 7
Biology of Melanocytes and Primary Melanoma
Zaidi, M. R., Fisher, D. E., & Rizos, H. (2018) · Springer eBooks · doi:10.1007/978-3-319-46029-1_42-1 · Cited by 7
Self-citationImmune checkpoint molecules: “new” kids on the block of skin photoimmunology
Wang, W., & Wu, Z. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.11.002 · Cited by 3
Tandukar, B., Kalapurakal, E., & Hornyak, T. J. (2021) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12959 · Cited by 4
“Development of inducible, Tet- on iDCT- GFP transgenic mice (Zaidi et al., 2011) represented an advance from Dct- LacZ mice.”
BackgroundSelf-citationSundberg, J. P., King, L. E., & Kuiper, R. (2021) · Wiley eBooks · doi:10.1002/9781119624608.ch10 · Cited by 4
Steele, E. J., & Lindley, R. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030989 · Cited by 4
“…at least can expect to be activated [75–77], causing expected collateral genomic damage via DNA deaminations [3,5] particularly in melanoma [78] and thus cancer pre-mutations—via C-to-U mutations at T=C and C=C cyclobutane pyrimidine dimers, involving error free DNA direct copying damage…”
McGrail, K., Granado‐Martínez, P., Orsenigo, R., Caratù, G., Nieto, P., Heyn, H., Fábrega, B. F., Hernández‐Losa, J., Muñoz‐Couselo, E., García‐Patos, V., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03339-7 · Cited by 6
Early exposure is inflammatory
McCarthy, N. J. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3020 · Cited by 3
May, K. F., Jinushi, M., & Dranoff, G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00008-7 · Cited by 4
Current Perspectives on Immunomodulation of NK Cells in Melanoma
Lakshmikanth, T., & Maria, H. (2011) · InTech eBooks · doi:10.5772/23903 · Cited by 4
Modeling tandem AAG8‐MEK inhibition in melanoma cells
Sun, B., Kawahara, M., & Nagamune, T. (2014) · Cancer Medicine · doi:10.1002/cam4.233 · Cited by 4
Making a mouse out of a molehill: how precision modeling repurposes drugs for congenital giant nevi
Grafanaki, K., Merlino, G. T., & Day, C. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.06.004 · Cited by 2
Self-citationSystemic immunosuppression from ultraviolet radiation exposure inhibits cancer immunotherapy
Durao, P., Budden, T., Mallela, K., Gutteridge, M., Mataloni, I., Gurung, S., Mastrangelo, M., Roberts, L. B., Banyard, A., Ashton, G., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012527 · Cited by 3
“6 7 15 Previous work shows that UVR leads to both local, cutaneous and systemic immuno-suppression, and systemic factors reduce anti-tumor immunity and support tumor growth.”
Handoko, H. Y., Rodero, M. P., Muller, H. K., Khosrotehrani, K., & Walker, G. J. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.203 · Cited by 2
Lu, C., Yang, Y., Zhang, M., Li, J., Song, H., Zhao, H., Mou, Y., Li, Y., & Song, X. (2024) · Head & Neck · doi:10.1002/hed.27707 · Cited by 2
Enhancement of mycobacterial pathogenesis by host interferon-γ
Hop, H. T., Liao, P., & Wu, H.-Y. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05425-7 · Cited by 2
TP 53 in the UV spotlight: a bona fide driver of melanoma
Hurlstone, A. F. L., & Wellbrock, C. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12302 · Cited by 2
Okwundu, N., Rahman, H., Liu, T., Florell, S. R., Boucher, K. M., & Grossman, D. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0399 · Cited by 2
Lei, R., Liu, X., & Wu, J. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad106 · Cited by 2
The Role of Macrophages in Pigmentary Disorders
Yao, H., Gao, X., & Xiang, W. (2025) · The Journal of Dermatology · doi:10.1111/1346-8138.70065 · Cited by 1
Lo, J. A., Rachmin, I., Flesher, J. L., Wu, X., Kawakami, A., Hejna, M., Boozer, J. R., Nguyen, N., King, A., Ji, Y., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.07.018 · Cited by 1
Inflammatory Reactions in Microenvironments, Leading to Melanomagenesis
Furukawa, K., Miyata, M., Kambe, M., Takeuchi, R., Bhuiyan, R. H., Zhang, P., Ohmi, Y., & Furukawa, K. (2017) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000508 · Cited by 1
“Generally, all these processes bring about inflammatory responses, promoting melanocyte survival and immunoevasion [31,32].”
BackgroundKilgour, J. M., & Sarin, K. Y. (2021) · Springer eBooks · doi:10.1007/978-3-030-82639-0_3 · Cited by 1
Aktary, Z., McMahon, M., & Larue, L. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7147-9_32 · Cited by 1
Time to Sleep: Immunologic Niche Switches Tumor Dormancy at Metastatic Sites
Nasrollahzadeh, E., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_58-1 · Cited by 1
The Role of the Immune System and Immunoregulatory Mechanisms Relevant to Melanoma
Haymaker, C., Sim, G. C., Forget, M., Chen, J. Q., Bernatchez, C., & Radvanyi, L. G. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3554-3_2 · Cited by 3
Levy, C., Golan, T., & Fisher, D. E. (2018) · Non-coding RNA Investigation · doi:10.21037/ncri.2018.04.05 · Cited by 1
Photocarcinogenesis and Molecular Mechanism
Agarwal, N. (2018) · Springer eBooks · doi:10.1007/978-981-10-5493-8_4 · Cited by 1
Borden, E. C. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00053-6 · Cited by 1
Tumor Microenvironment for Melanoma Cells
Wu, L. W., Herlyn, M., & Zhang, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-41319-8_14 · Cited by 1
The Photobiology of Human Skin
Norval, M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1468-5_24 · Cited by 1
Macrophage Response to Simulated Solar Radiation in the Development of Human Malignant Melanoma
Chu, S., Petukhova, T. A., Bordeaux, J. S., McCormick, T. S., & Cooper, K. D. (2021) · Archives of Clinical & Experimental Dermatology · doi:10.46527/2583-6374.119 · Cited by 1
Photocarcinogenesis and Inflammation
Nishigori, C. (2014) · Wiley eBooks · doi:10.1002/9781118826621.ch19 · Cited by 2
Mattaini, K. R., Sullivan, M. R., Lau, A. N., Fiske, B. P., Bronson, R. T., & Heiden, M. G. V. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/249250 · Cited by 1
Lin, F., & Young, H. A. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_411 · Cited by 3
Self-citationThibaut, R. (2019) · theses.fr (ABES) · doi:10.70675/ac790b4cz9f35z418cz89f3zeb164a5bcb06 · Cited by 1
Tumor Microenvironment for Melanoma Cells
Zhang, G., & Herlyn, M. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0371-5_14 · Cited by 1
Ultraviolet Light as a Modulator of Melanoma Development
Walker, G. J., & Hacker, E. (2011) · InTech eBooks · doi:10.5772/22928 · Cited by 2
“Zaidi et al. (2011) have cleverly utilized the power of the genetically modified mice to look into the mechanism of this melanocyte response.”
Early exposure is inflammatory
McCarthy, N. J. (2011) · Nature reviews. Immunology · doi:10.1038/nri2945
Wang, T., Yun, S. J., & Xu, X. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3554-3_1 · Cited by 1
Baquero, M. (2017) · The Atrium (University of Guelph)
Upregulation of Fanconi Anemia DNA Repair Genes in Melanoma Compared with Non-Melanoma Skin Cancer
Fanc, B., Fanc, C., Fanc, E., Fanc, F., Fanc, G., Fanc, L., Fanc, M., & Fanc, D. (2011)
Daniels, G. A. (2017) · Current cancer research · doi:10.1007/978-3-319-63757-0_11
Lin, F., & Young, H. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-67199-4_411
Self-citationKhanna, S., Ghazi, M., Subramaniam, Y. J., Sultan, F., Gupta, I., Sharma, K., Chandna, S., Gokhale, R. S., & Natarajan, V. T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.20.492761
Kituashvili, T., & Urushadze, T. (2023) · Georgian Biomedical News · doi:10.52340/gbmn.2023.01.01.21
Aggarwal, A., Nasreen, A., Sahoo, S., Faruq, M., Pandey, R., Jolly, M. K., Singh, A., Gokhale, R. S., & Natarajan, V. T. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.10.540111
INTERFERON-GAMMA: An Overview of its Origin, Mechanisms, and Functions in Health and Disease
Bafor, E. E., Bae, H. R., Valencia, J. C., & Young, H. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00047-8
Self-citationMutra, R., Mundodan, F., Vallem, A., Lawrie, C. H., Solé, C., Panizo, C., Ghatage, P., Anciya, V. R., & Vallabhapurapu, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.29.675399
Time to Sleep: Immunologic Niche Switches Tumor Dormancy at Metastatic Sites
Nasrollahzadeh, E., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_58 · Cited by 1
Screening de molécules antivirales actives sur le virus BK et compréhension du mécanisme d'action
Fiore, T. (2020) · theses.fr (ABES) · doi:10.70675/739c9512za8cbz4463z972bz023d80c26b17
Mucha, M., Ryšavá, A., Jarocka-Karpowicz, I., Maruška, A., Skrzydlewska, E., & Gęgotek, A. (2026) · Cells · doi:10.3390/cells15110965
“Consequently, the results of this study indicate UVA-induced increase in pro-inflammatory proteins, such as NF κ B1, IFN γ , and S100A8/9, which is consistent with the literature data [58,59].”
Tran, D., Vaska, A., Rayes, T. E., Lovinger, N., Elbanna, Y. A., Lee, E., Burd, C. E., Zippin, J. H., & Huse, M. (2026) · eLife · doi:10.64898/2026.05.27.728115
Orlow, I., Luo, L., Autuori, I., Mina, I., Mauguen, A., Edmiston, S. N., Gallagher, R. R., Ollila, D. W., Lee, T., BUSAM, K. J., et al. (2026) · Melanoma Research · doi:10.1097/cmr.0000000000001128
Jiang, T., Huang, X., Wu, Z., Abudusaimaiti, G., Song, Y., Duan, H., Zhou, Y., Chen, Y., Du, S., Zhang, H., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeg6398
“…immunosuppressive mediators, including indoleamine 2,3 dioxygenase 1 (IDO1) and PD L1 in tumor cells and tumor associated macrophages, and promotes suppressor of cy tokine signaling pathways in dendritic cells (DCs), collectively con tributing to an immunosuppressive tumor milieu ( 8 – 12 ).”
Metadata
- Authors
- Zaidi, M. R., Davis, S., Noonan, F. P., Graff-Cherry, C., Hawley, T. S., Walker, R. L., Feigenbaum, L., Fuchs, E., Lyakh, L., Young, H. A., Hornyak, T. J., Arnheiter, H., Trinchieri, G., Meltzer, P. S., De Fabo, E. C., & Merlino, G.
- Affiliations
- National Institutes of Health (US)
- George Washington University (US)
- Frederick National Laboratory for Cancer Research (US)
- Rockefeller University (US)
- National Cancer Institute (US)
- National Institute of Neurological Disorders and Stroke (US)
- Corresponding author
- Merlino, Glenn
- ORCID
- Venue
- Nature
- Published
- 2011-01
- Volume
- 469
- Issue
- 7331
- Pages
- 548-553
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3140101
- OpenAlex
- W2031502153
- Cited by
- 293
- References
- 46
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 21 · 2023: 17 · 2022: 12 · 2021: 14 · 2020: 17 · 2019: 19 · 2018: 22 · 2017: 30 · 2016: 13 · 2015: 19 · 2014: 27 · 2013: 22 · 2012: 19
- FWCI
- 14.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA053765, CA 92258, CA53765, R01CA092258)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- interferon-gamma, ultraviolet radiation, UV-B radiation, melanomagenesis, melanoma, macrophages, CCR2, melanocyte activation, immune evasion, melanoma treatment
- MeSH terms
- Animals, Disease Models, Animal, Female, Humans, Interferon-gamma, Macrophages, Male, Melanocytes, Melanoma, Ultraviolet Rays, Gene Expression Regulation, Developmental, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.